drugset / Trial / NCT04247230
Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation
Phase 1
Completed
20 enrolled
Futura Medical Developments Ltd.
Richmond Pharmacology Limited · collab
RandomizedSequentialOpen-labelBasic science
Summary
An open label, placebo and positive controlled, randomised, cross-over study in healthy male volunteers to determine the effect on penile skin sensation of a newly formulated tetracaine product PET500
Timeline
- Start
- 2008-09-03
- Primary completion
- 2008-10-20
- Completion
- 2009-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 23 mg | Topical |
| Subject | tetracaine | Other / unclassified | 0.26 mg | Topical |
| Subject | tetracaine | Other / unclassified | 0.65 mg | Topical |
| Subject | tetracaine | Other / unclassified | 1.3 mg | Topical |
Indications
No indication recorded.